Joaquín M. V.
- Country
- Spain
- Department
- Oncologia
Research Overview
- Evaluation of the Biological Effects of Saruparib (AZD5305) and Darolutamide, Alone and in Combination, in Patients with Newly Diagnosed Prostate Cancer Undergoing Radical Prostatectomy
- Evaluation of Safety, Pharmacokinetics, and Preliminary Efficacy of AMX-500 in Patients with Metastatic Castration-Resistant Prostate Cancer
- Phase 1 Evaluation of ORIC-944 in Patients with Metastatic Prostate Cancer
Data & Insights
Has run more than one trial at 129 of 306 partner sites.
Specializations
Prostate Cancer Treatment Innovation
The investigator specializes in treating various stages of prostate cancer, with particular emphasis on metastatic disease. Their research encompasses both hormone-sensitive and castration-resistant forms of the disease.
- Hormone-naïve prostate cancer
- Castration-sensitive prostate cancer
- Castration-resistant prostate cancer
Their work includes evaluation of novel therapeutic combinations for treating newly diagnosed and advanced cases.
Targeted Therapies
The investigator focuses on developing and implementing precision medicine approaches for prostate cancer treatment, particularly involving:
- PARP inhibitor therapies
- Androgen receptor pathway inhibitors
- T-cell redirecting agents
Their research includes investigation of biomarker-driven treatment strategies and genetic mutation-targeted therapies.
Advanced Cancer Research
The investigator conducts research in advanced oncology, exploring innovative treatment approaches for:
- Metastatic solid tumors
- Novel drug combinations
- Immunotherapy applications
Their work extends to evaluating biological effects of new therapeutic agents in various cancer stages.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.